#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13184	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2591	627.7	0	.	n	.	0	T1157C	SNP	1157	1157	T	1631	1631	C	835	C,T	834,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13184	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2591	627.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1924	1924	T	806	T,G	804,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13184	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2591	627.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1658	1658	C	838	C	838	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13184	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2591	627.7	0	HET	.	.	.	T536C,G	.	536	536	T	1010	1010	T	858	T,C,G	492,365,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13184	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2591	627.7	0	HET	.	.	.	C321T,A	.	321	321	C	795	795	C	761	C,T,A	564,196,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13184	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2591	627.7	0	HET	.	.	.	A337G	.	337	337	A	811	811	A	802	A,G	580,222	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22744	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4008	707.2	0	.	n	.	0	C1623T	SNP	1623	1623	C	2180	2180	T	852	T,C,G	844,4,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22744	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4008	707.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2528	2528	C	793	C,A	791,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22744	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4008	707.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2602	2602	A	787	A,G	786,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22744	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4008	707.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3154	3154	C	827	C	826	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2082	folP	855	855	100.0	folP.l15.c4.ctg.1	1949	133.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1244	1246	AGC	210;213;215	A;G;C	210;213;215	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4748	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3892	151.9	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1305	1307	ATA	179;177;179	A,T,C;T;A,T	177,1,1;177;178,1	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4748	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3892	151.9	1	SNP	p	S91F	0	.	.	271	273	TCC	828	830	TCC	168;166;167	T,A;C;C,T	167,1;166;166,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4748	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3892	151.9	1	SNP	p	D95N	0	.	.	283	285	GAC	840	842	GAC	175;174;176	G;A;C,T	175;174;175,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4748	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3892	151.9	1	SNP	p	D95G	0	.	.	283	285	GAC	840	842	GAC	175;174;176	G;A;C,T	175;174;175,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1766	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1877	117.1	1	SNP	p	G45D	1	.	.	133	135	GAC	717	719	GAC	219;220;219	G;A;C,T	219;220;218,1	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	966	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	1408	85.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4240	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3462	152.8	1	SNP	p	D86N	0	.	.	256	258	GAC	822	824	GAC	196;197;198	G;A;C,T	196;197;197,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4240	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3462	152.8	1	SNP	p	S87I	0	.	.	259	261	AGT	825	827	AGT	196;197;198	A;G;T	196;197;198	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4240	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3462	152.8	1	SNP	p	S87R	0	.	.	259	261	AGT	825	827	AGT	196;197;198	A;G;T	196;197;198	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4240	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3462	152.8	1	SNP	p	S87W	0	.	.	259	261	AGT	825	827	AGT	196;197;198	A;G;T	196;197;198	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4240	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3462	152.8	1	SNP	p	S88P	0	.	.	262	264	TCC	828	830	TCC	199;201;202	T;C;C	199;201;202	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3744	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3136	148.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1775	1777	GGC	213;209;213	G,C;G;C	212,1;209;213	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	3764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2880	162.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1455	1457	GCA	213;214;213	G;C,A;A,G	213;213,1;212,1	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2880	162.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1458	1460	ATC	210;212;209	A;T;C	210;212;209	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2880	162.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1470	1472	GTG	209;213;212	G;T,A;G	209;211,2;212	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2880	162.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1470	1472	GTG	209;213;212	G;T,A;G	209;211,2;212	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2880	162.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1974	1976	ACC	210;210;210	A,T;C;C	209,1;210;210	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2880	162.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2028	2030	GCG	201;205;207	G;C;G	201;205;207	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2880	162.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2028	2030	GCG	201;205;207	G;C;G	201;205;207	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2880	162.8	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2151	2153	GGT	197;197;198	G;G;T	197;197;198	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2880	162.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2160	2162	GGC	198;198;197	G,T;G;C	197,1;198;197	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2880	162.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2178	2180	CCG	209;208;208	C;C;G	208;208;208	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5008	ponA	2397	2397	99.83	ponA.l15.c4.ctg.1	3497	178.6	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1696	1698	ACG	207;207;209	A;C;G	207;207;209	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5008	ponA	2397	2397	99.83	ponA.l15.c4.ctg.1	3497	178.6	0	.	p	.	0	A471T	NONSYN	1411	1413	GCA	1984	1986	ACA	209;211;209	A;C;A,G	209;211;208,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5008	ponA	2397	2397	99.83	ponA.l15.c4.ctg.1	3497	178.6	0	.	p	.	0	T692M	NONSYN	2074	2076	ACG	2647	2649	ATG	219;217;216	A;T,C;G	218;215,1;215	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2098	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2318	112.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	867	867	C	153	C,T,G	151,1,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	286	porB1a	984	172	93.6	porB1a.l15.c4.ctg.2	172	53.0	0	.	p	.	0	A251V	NONSYN	751	753	GCG	10	12	GTG	21;22;22	G;T;G	21;22;22	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	286	porB1a	984	172	93.6	porB1a.l15.c4.ctg.2	172	53.0	0	.	p	.	0	S271T	NONSYN	811	813	TCG	70	72	ACT	73;73;73	A;C;T	73;73;73	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	286	porB1a	984	172	93.6	porB1a.l15.c4.ctg.2	172	53.0	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	76	78	GAT	73;73;73	G;A;T	73;73;73	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	286	porB1a	984	172	93.6	porB1a.l15.c4.ctg.2	172	53.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	79	81	AGT	73;73;73	A;G;T	73;73;73	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	286	porB1a	984	172	93.6	porB1a.l15.c4.ctg.2	172	53.0	0	.	p	.	0	N277H	NONSYN	829	831	AAC	88	90	CAC	73;73;73	C;A;C	73;73;73	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	G46S	NONSYN	136	138	GGC	677	679	AGC	215;217;217	A;G,T;C	215;216,1;216	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	S54A	NONSYN	160	162	TCC	701	703	GCC	228;228;228	G;C,A;C	228;227,1;228	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	K120D	NONSYN	358	360	AAG	899	901	GAC	209;207;208	G;A;C,T	209;207;207,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	A151V	NONSYN	451	453	GCA	992	994	GTA	190;187;188	G,A,C;T,G;A,C	188,1,1;186,1;187,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	A213S	NONSYN	637	639	GCA	1178	1180	TCA	232;234;238	T;C;A	232;234;238	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1298	1300	CAA	170;172;171	C,A;A;A	168,1;170;170	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	.	INDELS	760	761	AC	1302	1305	ATCA	165;164;160;157	A;T,C;C;A	165;163,1;159;157	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	.	MULTIPLE	764	765	AC	1310	1312	GTG	158;156;156	G;T,G;G,A	157;155,1;154,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1316	1318	GAT	155;157;160	G,T;A,C;T,C	154,1;156,1;159,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	A270V	NONSYN	808	810	GCG	1355	1357	GTG	169;169;165	G;T,C;G	169;168,1;165	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	L277V	NONSYN	829	831	TTA	1376	1378	GTA	160;161;162	G,C;T;A	159,1;161;162	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	S290T	NONSYN	868	870	TCT	1415	1417	ACT	182;184;186	A;C;T	182;184;186	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	H292D	NONSYN	874	876	CAT	1421	1423	GAT	190;192;193	G;A;T	190;192;193	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2426	porB1b	1041	1041	97.52	porB1b.l15.c4.ctg.1	2123	142.6	0	.	p	.	0	Y296H	NONSYN	886	888	TAC	1433	1435	CAC	206;205;207	C;A,G;C	206;204,1;207	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9152	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5193	219.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2218	2220	CAT	260;261;259	C,G;A,G;T	259,1;259,2;259	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1396	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1408	123.6	1	SNP	p	V57M	1	.	.	169	171	ATG	721	723	ATG	272;272;274	A;T;G,A	272;272;273,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	10978	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	3033	450.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
